Function and regulation of the ISG15 specific isopeptidase USP18
Function and regulation of the ISG15 specific isopeptidase USP18
批准号:
325088716
负责人:
Privatdozent Dr. Klaus-Peter Knobeloch
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2017
资助国家:
德国
项目状态:
已结题
起止时间:
2016-12-31 至 2020-12-31
中文摘要
泛素(Ub)和泛素样蛋白(UBL)如SUMO、NEDD 8、FAT 10或Hub 1对蛋白质的修饰影响多效性生物学功能,并被Ub/UBL解偶联蛋白抵消。干扰素刺激基因15(Interferon stimulated gene 15,ISG 15)是一种UBL,其可以在类似于泛素的过程中与靶底物缀合(ISGylation),并且代表主要的I型干扰素(IFN)效应子系统。ISGylation针对病毒和细菌病原体,但也涉及其他过程,包括DNA修复和肿瘤发生。ISG化被ISG 15特异性异肽酶USP 18逆转。使用敲入小鼠,我们最近表明,USP 18的蛋白酶功能的选择性失活抑制病毒载量,这表明USP 18蛋白酶抑制可能构成一种有前途的抗病毒策略。到目前为止,只有少数与USP 18相互作用的蛋白被鉴定出来,而关于其他蛋白如何影响USP 18或USP 18如何调节结合伴侣的功能知之甚少。使用酵母双杂交筛选,我们现在已经鉴定了几种USP 18相互作用蛋白,其暗示USP 18与NFk-B信号通路和表观遗传调控的串扰。在本提案的范围内,我们将使用基于生物化学和细胞的方法分析这些相互作用伴侣和USP 18的功能关系。不考虑其蛋白酶活性,USP 18代表IFN应答的主要负调节剂。因此,我们和其他人最近的工作表明,USP 18的缺失导致小鼠小胶质细胞自发的异常激活,并导致人类胚胎中致命的干扰素病。尽管具有临床相关性,但不受控制的炎症反应的初始触发因素的性质仍有待确定。我们将通过经典的遗传拯救方法来解决这个问题,使用USP 18的双k.o小鼠,结合危险/病原体信号触发途径(如MAVS、MYD 88、STING等)的关键信号分子的耗竭。到目前为止,功能/表型关系的分析受到USP 18-/-小鼠表型中巨大遗传背景依赖性变异的阻碍。我们实验室中产生的条件性USP 18fl/fl小鼠现在将允许我们研究时空控制的USP 18消耗对充分表征的C57/BL 6菌株的后果。此外,C57/BL 6品系中USP 18-/-小鼠的胚胎致死率(构成了人体USP 18缺乏症后果的良好动物模型)有待于本研究中解决的机制探索。总的来说,我们希望我们的研究结果将增强对USP 18功能,其调节及其对相互作用蛋白质的影响的理解。研究结果还有助于深入了解导致USP 18缺陷型人类胚胎死亡的机制,以及一般有害的炎症反应(例如先天性感染引起的炎症反应)。
英文摘要
Protein modification by ubiquitin (Ub) and ubiquitin like proteins (UBLs) such as SUMO, NEDD8, FAT10 or Hub1 affect pleiotropic biological functions and are counteracted by Ub/UBL deconjugating proteins. Interferon stimulated gene 15 (ISG15) is an UBL, which can be conjugated to target substrates (ISGylation) in a process similar to ubiquitin and represents a major type I interferon (IFN) effector system. ISGylation is directed against viral and bacterial pathogens but is also involved in other processes including DNA repair and tumorigenesis. ISGylation is reversed by the ISG15-specific isopeptidase USP18. Using Knock-In mice, we recently showed that selective inactivation of the protease function of USP18 suppressed viral load suggesting that USP18 protease inhibition could constitute a promising antiviral strategy. So far, only a few proteins interacting with USP18 were identified and little is known about how other proteins influence USP18 or how USP18 regulates the function of binding partners. Using a yeast two hybrid screen, we have now identified several USP18 interacting proteins which hint to a crosstalk of USP18 with the NFk-B signaling pathway and epigenetic regulation. Within the scope of this proposal, we will analyze the functional relationship of these interaction partners and USP18 using biochemical and cell based approaches. Irrespective of its protease activity, USP18 represents a major negative regulator of the IFN response. Consequently, recent work by us and others showed that loss of USP18 results in spontaneous, aberrant activation of microglia in mice and causes fatal interferonopathies in human embryos. Despite the clinical relevance, the nature of the initial trigger for the uncontrolled inflammatory response still remains to be defined. We will address this question by classical genetic rescue approaches using double k.o mice for USP18 in combination with depletion of key signaling molecules of danger/pathogen signal triggered pathways such as MAVS, MYD88, STING etc. Until now, analysis of the function/phenotype relationship was hampered by a great genetic background dependent variability in the phenotype of USP18-/- mice. The conditional USP18fl/fl mice generated in our lab will now allow us to investigate the consequences of spatiotemporal controlled USP18 depletion on the well characterized C57/BL6 strain. Furthermore, embryonic lethality of USP18-/- mice in the C57/BL6 strain, which constitutes a good animal model for the consequences of USP18 deficiency in humans, awaits mechanistic exploration which will be addressed in this study. Collectively we expect that our results will enhance the understanding of USP18 function, its regulation and of its influence on interacting proteins. Results should also help to gain insights into the mechanisms responsible for the death of USP18 deficient human embryos in particular and for detrimental inflammatory responses (e.g. those caused by congenital infections) in general.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/s41586-020-2601-5
发表时间:
2020-07-29
期刊:
NATURE
影响因子:
64.8
作者:
[Shin, Donghyuk, Mukherjee, Rukmini, Dikic, Ivan]
通讯作者:
Dikic, Ivan
DOI:
10.1038/s41467-021-26061-w
发表时间:
2021-10-01
期刊:
Nature communications
影响因子:
16.6
作者:
[Thery F, Martina L, Asselman C, Zhang Y, Vessely M, Repo H, Sedeyn K, Moschonas GD, Bredow C, Teo QW, Zhang J, Leandro K, Eggermont D, De Sutter D, Boucher K, Hochepied T, Festjens N, Callewaert N, Saelens X, Dermaut B, Knobeloch KP, Beling A, Sanyal S, Radoshevich L, Eyckerman S, Impens F]
通讯作者:
Impens F
Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage
DOI:
10.1083/jcb.202002175
发表时间:
2020-08-03
期刊:
JOURNAL OF CELL BIOLOGY
影响因子:
7.8
作者:
[Raso, Maria Chiara, Djoric, Nikola, Penengo, Lorenza]
通讯作者:
Penengo, Lorenza
Loss of USP18 in microglia induces white matter pathology
小胶质细胞中 USP18 的缺失会诱发白质病理
DOI:
10.1186/s40478-019-0757-8
发表时间:
2019
期刊:
Acta Neuropathologica Communications
影响因子:
7.1
作者:
[Schwabenland M, Mossad O, Peres AG, Kessler F, Maron FJM, Harsan LA, Bienert T, von Elverfeldt D, Knobeloch KP, Staszewski O, Heppner FL, Meuwissen MEC, Mancini GMS, Prinz M, Blank T]
通讯作者:
Blank T
DOI:
10.1126/sciadv.aay1109
发表时间:
2020-03-01
期刊:
SCIENCE ADVANCES
影响因子:
13.6
作者:
[Kespohl, Meike, Bredow, Clara, Beling, Antje]
通讯作者:
Beling, Antje
Enzymatic and non-enzymatic functions of the SUMO isopeptidase USPL1 in vivo
-
批准号:398279577
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Privatdozent Dr. Klaus-Peter Knobeloch
-
依托单位:
Regulation of antiviral immunity and autoimmune inflammation by the deubiquitinating enzyme USP15
-
批准号:407678805
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Privatdozent Dr. Klaus-Peter Knobeloch
-
依托单位:
Analysis of the ISG15 conjugation and deconjugation system in vivo
-
批准号:71963973
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Privatdozent Dr. Klaus-Peter Knobeloch
-
依托单位:
Functional role of the ubiquitin specific protease 8 (USP8/UBPy) in T cells
-
批准号:79091578
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:Privatdozent Dr. Klaus-Peter Knobeloch
-
依托单位:
Analyse der Funktion der Ubiquitin Isopeptidase UBPy (USP8) in vivo
-
批准号:31414656
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Privatdozent Dr. Klaus-Peter Knobeloch
-
依托单位:
Analysis of ISG15 effector functions in vivo
-
批准号:5423693
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Privatdozent Dr. Klaus-Peter Knobeloch
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
-
批准号:82371770
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:宁铂涛
-
依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
-
批准号:82371379
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:冯军峰
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
mPFC-VTA-NAc多巴胺能投射调控丙泊酚麻醉—觉醒的机制研究
-
批准号:82371284
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:许涛
-
依托单位: